Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Federazione Diabete GiovanilefiledCriticalFederazione Diabete Giovanile
Priority to ITRM20050522priorityCriticalpatent/ITRM20050522A1/en
Publication of ITRM20050522A1publicationCriticalpatent/ITRM20050522A1/en
Compounds derived from 4,5-dihydro-oxazol-2-ylamine; preparation procedure; pharmaceutical composition; and its use for the treatment of Alzheimer's disease.
COMPOUNDS DERIVED FROM PIRAZIN-2-ONA; PHARMACEUTICAL COMBINATION; AND USE IN THE TREATMENT OF DISEASES SUCH AS DIABETES, ATEROSCLEROSIS, HYPERTENSION, AMONG OTHERS.
Substituted 2-amino-acetamide derived compounds; pharmaceutical composition; Useful in the treatment of lung diseases, rheumatic disease, autoimmune disease, among others.
ACID DERIVATIVES 3-METHYL-2- (3- (2-PHENYL-OXAZOL-4-ILMETOXI) -CICLOHEXANOCARBONIL-AMINOBUTÍRICO AND RELATED COMPOUNDS AS PPAR MODULATORS FOR THE TREATMENT OF TYPE 2 DIABETES AND ATEROSCLEROSIS
MACROCICLICAL COMPOUNDS DERIVED FROM 6-ARIL-4-MERCAPTO- [1.3.5] TRIAZINA / [1.3] PIRIMIDIN-2-AMINA; PHARMACEUTICAL COMPOSITION, USEFUL IN THE TREATMENT OF CANCER.
Benzenesulfonanilide derived compounds; pharmaceutical composition comprising them; and use in the treatment of diseases of the central nervous system, cognitive dysfunctions, schizophrenia, addictive diseases, Alzheimer's disease or obesity.